In approximately 70% of cases of ovarian cancer, PI3K/AKT/mTOR pathways have been shown to be constitutively triggered by autophagy, which has been considered to be a therapeutic target of ovarian cancer [79]. The gene discussed is MTOR; the disease is ovarian cancer.